Caplacizumab-yhdp and Estrogens (Conjugated B/Synthetic)
Determining the interaction of Caplacizumab-yhdp and Estrogens (Conjugated B/Synthetic) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: caplacizumab
Brand name: Cablivi
Synonyms: Caplacizumab
Generic Name: conjugated estrogens
Brand name: Enjuvia, Premarin, Premarin Intravenous, Cenestin
Synonyms: Conjugated estrogens, Estrogens (Conjugated A/Synthetic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Caplacizumab-yhdp-Estrogens (Conjugated/Equine) and Bazedoxifene
- Caplacizumab-yhdp-Estrogens (Conjugated/Equine) and Medroxyprogesterone
- Caplacizumab-yhdp-Estrogens (Conjugated/Equine, Systemic)
- Caplacizumab-yhdp-Estrogens (Conjugated/Equine, Topical)
- Caplacizumab-yhdp-Estrogens (Esterified)
- Caplacizumab-yhdp-Estrogens (Esterified) and Methyltestosterone
- Estrogens (Conjugated B/Synthetic)-Capmist DM
- Estrogens (Conjugated B/Synthetic)-Capoten
- Estrogens (Conjugated B/Synthetic)-Capozide
- Estrogens (Conjugated B/Synthetic)-Capozide 25/15
- Estrogens (Conjugated B/Synthetic)-Capozide 25/25
- Estrogens (Conjugated B/Synthetic)-Capozide 50/15